CN Patent

CN101257800B — 包含法莫替丁和布洛芬的药物

Assigned to Horizon Therapeutics LLC · Expires 2012-07-18 · 14y expired

What this patent protects

一种向需要布洛芬治疗的患者给药的方法被提供，其中，包括治疗有效量的布洛芬和治疗有效量的法莫替丁混合物的口服剂型被每天三次给药。

USPTO Abstract

一种向需要布洛芬治疗的患者给药的方法被提供，其中，包括治疗有效量的布洛芬和治疗有效量的法莫替丁混合物的口服剂型被每天三次给药。

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: CN101257800B
Jurisdiction: CN
Classification: —
Expires: 2012-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Horizon Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.